期刊文献+

大鼠变应性鼻炎模型鼻粘膜P物质受体mRNA的表达 被引量:25

Expression of substance P receptor mRNA in nasal mucosa of rat in allergic rhinitis model
暂未订购
导出
摘要 目的 探讨大鼠鼻粘膜P物质受体 (substancePreceptor,SP R)mRNA的表达水平及其与变应性鼻炎的关系。方法 选健康Wistar大鼠 2 0只 ,雌雄不限 ,随机分为实验组和对照组各 10只。实验组用卵清蛋白行腹腔注射基础致敏 ,继之鼻局部激发建立大鼠变应性鼻炎模型。以 β 肌动蛋白 (β actin)作内标准 ,利用逆转录 多聚酶链反应 (reversetranscriptivepolymerasechainreaction ,RT PCR) ,对变应性鼻炎模型组和对照组大鼠鼻粘膜SP RmRNA进行了定量研究。同时利用地高辛标记的cDNA探针对其行Southern杂交鉴定。结果 对照组和实验组大鼠鼻粘膜中均有SP RmRNA表达 ,但实验组大鼠中SP RmRNA表达量较对照组明显增多 (P <0 .0 5 )。结论 变应性鼻炎鼻粘膜SP RmRNA表达量增多 ,提示SP RmRNA表达上调在变应性鼻炎的发生发展中起作用。 Objective To study the expression of substance P receptor messenger RNA (SP-R mRNA) in nasal mucosa in allergic rhinitis (AR) rat model. Methods Twenty Wistar rats free of disease were randomly divided into two groups. AR model rats were established through repeated intraperitoneal shot of ovalbumin (OV) and consequently confirmed by local challenge with OV. SP-R mRNA in nasal mucosa, obtained from two groups, were used to do reverse transcriptive polymerase chain reaction (RT-PCR) and Southern blot. β-actin was used as a standard control through out the whole process. Results The results showed definitely that there were positive expression of SP-R mRNA in normal nasal mucosa. This expressions increased significantly ( P <0.05) during nasal allergy. Conclusion Increased expression SP-R mRNA in nasal mucosa in AR model might play roles in the development of AR.
出处 《中华耳鼻咽喉科杂志》 CSCD 2000年第4期247-250,共4页 Chinese Journal of Otorhinolaryngology
基金 山西省自然科学基金!资助项目 (981 60 8)
关键词 变应性鼻炎 鼻粘膜P物质 MRNA 大鼠 Rhinitis,allergic,nonseasonal Receptors,neurokinin-1 Molecular biology Rat
  • 相关文献

参考文献1

二级参考文献26

  • 1陶正德.常年性鼻炎发病中的有关问题[J].中华耳鼻咽喉科杂志,1994,29(4):243-246. 被引量:15
  • 2崔新乐,朱元珏.过敏性哮喘速发反应、迟发反应与持续气道高反应性及其机制[J].国外医学(内科学分册),1996,23(11):470-473. 被引量:5
  • 3周武庆,李义梅.P物质与炎症研究进展[J].国外医学(免疫学分册),1997,20(2):95-98. 被引量:26
  • 4Pawankar RU, Okuda M, Okubo K, et al. Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis.Am J Respir Crit Care Med, 1995,152:2049-2058.
  • 5Durham SR, Ying S, Varney VA, et al. Cytokine Messenger RNA expression for IL-3, IL-4, IL-5 and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation : relationship to tissue eosinophilia.J Immunol, 1992,148:2390-2394.
  • 6Terada N. Konno A, Togawa K. Biochemical properties of eosinophil and their preferential accumulation mechanism in nasal allergy. J Allergy C1in Immunol, 1994, 94 : 629-642.
  • 7Bradding P. Feather IH, Howarth PH, et al. Interleukin 4 is localized to and released by human mast cells, J Exp.Med, 1992,176:1381 - 1386.
  • 8Lee BJ, Naclerio RM, Bochner BS, et al. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol,1994, 94:1006 - 1016.
  • 9Bowden JJ, Garland AM, Baluk P, et al. Direr observation of substance P induced intermalization of neurokinin 1(NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA, 1994, 99 : 8964-8968.
  • 10DeRose V, Robbins RA, Snider RM, et al. Substance P increases neutrophil adhension to bronchial epithelial cells. J Immunol, 1994: 152:1339-1346.

共引文献8

同被引文献195

引证文献25

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部